Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study

José R. Romero, Alexa Beiser, Jayandra J. Himali, Ashkan Shoamanesh, Charles DeCarli, Sudha Seshadri

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cerebral microbleeds (CMBs) are MRI markers attributed to the most common cerebral angiopathies in the elderly and in patients with dementia: hypertensive and cerebral amyloid angiopathy. CMB detection in asymptomatic persons may help identify those at risk for dementia and may influence preventive strategies and design of clinical trials testing treatments for dementia. We studied the association of CMB with risk of incident dementia in community dwelling individuals. A total of 1296 dementia-free Framingham Heart Study participants (mean age 72 years; 54% women) with available brain MRI and incident dementia data during a mean follow-up period of 6.7 years were included. Using Cox proportional hazards models, we related CMB presence to incident dementia. Multivariable models were adjusted for age, sex, APOE status, and education, with additional models adjusting for vascular risk factors and MRI markers of ischemic brain injury. CMBs were observed in 10.8% and incident dementia in 85 participants (6.6% over study period). Participants with any CMB had 1.74 times higher risk of dementia (hazard ratio [HR] 1.74, 95% confidence interval [CI] 1.00–3.01), whereas those with deep and mixed CMB had a three-fold increased risk (HR 2.99, 95% CI 1.52–5.90). The associations were independent of vascular risk factors, and for deep and mixed CMB also independent of MRI markers of ischemia (HR 2.44, 95% CI 1.22–4.88). Purely lobar CMBs were not associated with incident dementia. Our findings support a role for hypertensive vasculopathy and the interplay of hypertensive and cerebral amyloid angiopathy in risk of dementia and suggest that CMB presence can identify individuals at risk of dementia.

Original languageEnglish (US)
Pages (from-to)94-99
Number of pages6
JournalNeurobiology of Aging
Volume54
DOIs
StatePublished - Jun 1 2017

Fingerprint

Dementia
Cerebral Amyloid Angiopathy
Confidence Intervals
Independent Living
Proportional Hazards Models
Brain Injuries
Ischemia
Odds Ratio
Clinical Trials
Education
Brain

Keywords

  • Brain MRI
  • Cerebral microbleeds
  • Cerebral small vessel disease
  • Dementia

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

Cerebral microbleeds and risk of incident dementia : the Framingham Heart Study. / Romero, José R.; Beiser, Alexa; Himali, Jayandra J.; Shoamanesh, Ashkan; DeCarli, Charles; Seshadri, Sudha.

In: Neurobiology of Aging, Vol. 54, 01.06.2017, p. 94-99.

Research output: Contribution to journalArticle

Romero, José R. ; Beiser, Alexa ; Himali, Jayandra J. ; Shoamanesh, Ashkan ; DeCarli, Charles ; Seshadri, Sudha. / Cerebral microbleeds and risk of incident dementia : the Framingham Heart Study. In: Neurobiology of Aging. 2017 ; Vol. 54. pp. 94-99.
@article{1e7a4ef10656460c9949cb1e6c7c8cef,
title = "Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study",
abstract = "Cerebral microbleeds (CMBs) are MRI markers attributed to the most common cerebral angiopathies in the elderly and in patients with dementia: hypertensive and cerebral amyloid angiopathy. CMB detection in asymptomatic persons may help identify those at risk for dementia and may influence preventive strategies and design of clinical trials testing treatments for dementia. We studied the association of CMB with risk of incident dementia in community dwelling individuals. A total of 1296 dementia-free Framingham Heart Study participants (mean age 72 years; 54{\%} women) with available brain MRI and incident dementia data during a mean follow-up period of 6.7 years were included. Using Cox proportional hazards models, we related CMB presence to incident dementia. Multivariable models were adjusted for age, sex, APOE status, and education, with additional models adjusting for vascular risk factors and MRI markers of ischemic brain injury. CMBs were observed in 10.8{\%} and incident dementia in 85 participants (6.6{\%} over study period). Participants with any CMB had 1.74 times higher risk of dementia (hazard ratio [HR] 1.74, 95{\%} confidence interval [CI] 1.00–3.01), whereas those with deep and mixed CMB had a three-fold increased risk (HR 2.99, 95{\%} CI 1.52–5.90). The associations were independent of vascular risk factors, and for deep and mixed CMB also independent of MRI markers of ischemia (HR 2.44, 95{\%} CI 1.22–4.88). Purely lobar CMBs were not associated with incident dementia. Our findings support a role for hypertensive vasculopathy and the interplay of hypertensive and cerebral amyloid angiopathy in risk of dementia and suggest that CMB presence can identify individuals at risk of dementia.",
keywords = "Brain MRI, Cerebral microbleeds, Cerebral small vessel disease, Dementia",
author = "Romero, {Jos{\'e} R.} and Alexa Beiser and Himali, {Jayandra J.} and Ashkan Shoamanesh and Charles DeCarli and Sudha Seshadri",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.neurobiolaging.2017.02.018",
language = "English (US)",
volume = "54",
pages = "94--99",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Cerebral microbleeds and risk of incident dementia

T2 - the Framingham Heart Study

AU - Romero, José R.

AU - Beiser, Alexa

AU - Himali, Jayandra J.

AU - Shoamanesh, Ashkan

AU - DeCarli, Charles

AU - Seshadri, Sudha

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Cerebral microbleeds (CMBs) are MRI markers attributed to the most common cerebral angiopathies in the elderly and in patients with dementia: hypertensive and cerebral amyloid angiopathy. CMB detection in asymptomatic persons may help identify those at risk for dementia and may influence preventive strategies and design of clinical trials testing treatments for dementia. We studied the association of CMB with risk of incident dementia in community dwelling individuals. A total of 1296 dementia-free Framingham Heart Study participants (mean age 72 years; 54% women) with available brain MRI and incident dementia data during a mean follow-up period of 6.7 years were included. Using Cox proportional hazards models, we related CMB presence to incident dementia. Multivariable models were adjusted for age, sex, APOE status, and education, with additional models adjusting for vascular risk factors and MRI markers of ischemic brain injury. CMBs were observed in 10.8% and incident dementia in 85 participants (6.6% over study period). Participants with any CMB had 1.74 times higher risk of dementia (hazard ratio [HR] 1.74, 95% confidence interval [CI] 1.00–3.01), whereas those with deep and mixed CMB had a three-fold increased risk (HR 2.99, 95% CI 1.52–5.90). The associations were independent of vascular risk factors, and for deep and mixed CMB also independent of MRI markers of ischemia (HR 2.44, 95% CI 1.22–4.88). Purely lobar CMBs were not associated with incident dementia. Our findings support a role for hypertensive vasculopathy and the interplay of hypertensive and cerebral amyloid angiopathy in risk of dementia and suggest that CMB presence can identify individuals at risk of dementia.

AB - Cerebral microbleeds (CMBs) are MRI markers attributed to the most common cerebral angiopathies in the elderly and in patients with dementia: hypertensive and cerebral amyloid angiopathy. CMB detection in asymptomatic persons may help identify those at risk for dementia and may influence preventive strategies and design of clinical trials testing treatments for dementia. We studied the association of CMB with risk of incident dementia in community dwelling individuals. A total of 1296 dementia-free Framingham Heart Study participants (mean age 72 years; 54% women) with available brain MRI and incident dementia data during a mean follow-up period of 6.7 years were included. Using Cox proportional hazards models, we related CMB presence to incident dementia. Multivariable models were adjusted for age, sex, APOE status, and education, with additional models adjusting for vascular risk factors and MRI markers of ischemic brain injury. CMBs were observed in 10.8% and incident dementia in 85 participants (6.6% over study period). Participants with any CMB had 1.74 times higher risk of dementia (hazard ratio [HR] 1.74, 95% confidence interval [CI] 1.00–3.01), whereas those with deep and mixed CMB had a three-fold increased risk (HR 2.99, 95% CI 1.52–5.90). The associations were independent of vascular risk factors, and for deep and mixed CMB also independent of MRI markers of ischemia (HR 2.44, 95% CI 1.22–4.88). Purely lobar CMBs were not associated with incident dementia. Our findings support a role for hypertensive vasculopathy and the interplay of hypertensive and cerebral amyloid angiopathy in risk of dementia and suggest that CMB presence can identify individuals at risk of dementia.

KW - Brain MRI

KW - Cerebral microbleeds

KW - Cerebral small vessel disease

KW - Dementia

UR - http://www.scopus.com/inward/record.url?scp=85016035988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016035988&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2017.02.018

DO - 10.1016/j.neurobiolaging.2017.02.018

M3 - Article

C2 - 28347929

AN - SCOPUS:85016035988

VL - 54

SP - 94

EP - 99

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

ER -